Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated to Revision: v3.0.2 and removed 'Back to Top'.
    Difference
    0.1%
    Check dated 2025-09-13T01:46:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-05T19:59:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of specific facility names and locations related to plasma cell myeloma, while also removing previous mentions of multiple myeloma and related terms.
    Difference
    2%
    Check dated 2025-08-29T18:56:49.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-15T12:35:41.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T09:18:37.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-01T06:23:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.